Your browser doesn't support javascript.
loading
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
McKay, James D; Hung, Rayjean J; Han, Younghun; Zong, Xuchen; Carreras-Torres, Robert; Christiani, David C; Caporaso, Neil E; Johansson, Mattias; Xiao, Xiangjun; Li, Yafang; Byun, Jinyoung; Dunning, Alison; Pooley, Karen A; Qian, David C; Ji, Xuemei; Liu, Geoffrey; Timofeeva, Maria N; Bojesen, Stig E; Wu, Xifeng; Le Marchand, Loic; Albanes, Demetrios; Bickeböller, Heike; Aldrich, Melinda C; Bush, William S; Tardon, Adonina; Rennert, Gad; Teare, M Dawn; Field, John K; Kiemeney, Lambertus A; Lazarus, Philip; Haugen, Aage; Lam, Stephen; Schabath, Matthew B; Andrew, Angeline S; Shen, Hongbing; Hong, Yun-Chul; Yuan, Jian-Min; Bertazzi, Pier Alberto; Pesatori, Angela C; Ye, Yuanqing; Diao, Nancy; Su, Li; Zhang, Ruyang; Brhane, Yonathan; Leighl, Natasha; Johansen, Jakob S; Mellemgaard, Anders; Saliba, Walid; Haiman, Christopher A; Wilkens, Lynne R.
Afiliación
  • McKay JD; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Hung RJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Han Y; Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Zong X; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Carreras-Torres R; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Christiani DC; Department of Environmental Health, Harvard T.H. Chan School of Public Health and Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, USA.
  • Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA.
  • Johansson M; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Xiao X; Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Li Y; Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Byun J; Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Dunning A; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Pooley KA; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Qian DC; Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Ji X; Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Liu G; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Timofeeva MN; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Bojesen SE; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Wu X; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Le Marchand L; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark.
  • Albanes D; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bickeböller H; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
  • Aldrich MC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA.
  • Bush WS; Department of Genetic Epidemiology, University Medical Center, Georg August University Göttingen, Göttingen, Germany.
  • Tardon A; Department of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Rennert G; Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • Teare MD; University of Oviedo and CIBERESP, Faculty of Medicine, Oviedo, Spain.
  • Field JK; Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
  • Kiemeney LA; School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Lazarus P; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Haugen A; Departments of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Lam S; Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, Washington, USA.
  • Schabath MB; National Institute of Occupational Health, Oslo, Norway.
  • Andrew AS; British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Shen H; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Hong YC; Department of Epidemiology, Geisel School of Medicine, Hanover, New Hampshire, USA.
  • Yuan JM; Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Bertazzi PA; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Pesatori AC; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
  • Ye Y; Department of Preventive Medicine, IRCCS Foundation Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Diao N; Department of Clinical Sciences and Community Health-DISCCO, University of Milan, Milan, Italy.
  • Su L; Department of Clinical Sciences and Community Health-DISCCO, University of Milan, Milan, Italy.
  • Zhang R; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Brhane Y; Department of Environmental Health, Harvard T.H. Chan School of Public Health and Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, USA.
  • Leighl N; Department of Environmental Health, Harvard T.H. Chan School of Public Health and Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, USA.
  • Johansen JS; Department of Environmental Health, Harvard T.H. Chan School of Public Health and Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, USA.
  • Mellemgaard A; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Saliba W; University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Haiman CA; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Wilkens LR; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Nat Genet ; 49(7): 1126-1132, 2017 Jul.
Article en En | MEDLINE | ID: mdl-28604730
Although several lung cancer susceptibility loci have been identified, much of the heritability for lung cancer remains unexplained. Here 14,803 cases and 12,262 controls of European descent were genotyped on the OncoArray and combined with existing data for an aggregated genome-wide association study (GWAS) analysis of lung cancer in 29,266 cases and 56,450 controls. We identified 18 susceptibility loci achieving genome-wide significance, including 10 new loci. The new loci highlight the striking heterogeneity in genetic susceptibility across the histological subtypes of lung cancer, with four loci associated with lung cancer overall and six loci associated with lung adenocarcinoma. Gene expression quantitative trait locus (eQTL) analysis in 1,425 normal lung tissue samples highlights RNASET2, SECISBP2L and NRG1 as candidate genes. Other loci include genes such as a cholinergic nicotinic receptor, CHRNA2, and the telomere-related genes OFBC1 and RTEL1. Further exploration of the target genes will continue to provide new insights into the etiology of lung cancer.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estudio de Asociación del Genoma Completo / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2017 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estudio de Asociación del Genoma Completo / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2017 Tipo del documento: Article País de afiliación: Francia